,Set,NGenes,Direction,PValue,FDR
1,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Up,5.37632390340088e-09,4.41933824859553e-06
2,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,15,Down,6.26110095292955e-08,2.57331249165405e-05
3,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,37,Down,7.86216788581479e-06,0.00192061628917111
4,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Down,1.10137792286458e-05,0.00192061628917111
5,WP_HYPERTROPHY_MODEL,13,Down,1.16825808343742e-05,0.00192061628917111
6,WP_PROSTAGLANDIN_SIGNALING,22,Down,1.4691798279559e-05,0.00201277636429958
7,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,29,Down,2.53044195241561e-05,0.00276476540712185
8,WP_IL26_SIGNALING,31,Down,2.740567971556e-05,0.00276476540712185
9,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,11,Down,3.0271154092575e-05,0.00276476540712185
10,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,17,Down,4.59758677123584e-05,0.00328781164259807
11,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,4.7095695262247e-05,0.00328781164259807
12,WP_COMPLEMENT_ACTIVATION,12,Up,4.79972502569061e-05,0.00328781164259807
13,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,24,Down,7.04726848907919e-05,0.00445604207540238
14,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Down,7.81473730011649e-05,0.00458836718621125
15,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,28,Down,0.000108135650978894,0.00592583367364337
16,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,33,Down,0.00013891810996827,0.00713691789961988
17,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Down,0.000178133661548463,0.00861328645840216
18,WP_SPINAL_CORD_INJURY,66,Down,0.000204914175965924,0.00935774736911053
19,WP_MEVALONATE_PATHWAY,7,Down,0.000236844150352226,0.0102466258731331
20,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,78,Down,0.000254200521749945,0.0104476414439228
21,WP_GASTRIN_SIGNALING,94,Down,0.000272998610897297,0.0105253651699473
22,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,15,Down,0.000289220670084182,0.0105253651699473
23,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,7,Down,0.000294505351470545,0.0105253651699473
24,WP_IL1_SIGNALING,54,Down,0.000412253310278339,0.0141196758770331
25,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,33,Down,0.000480172876966852,0.0157631668795898
26,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Down,0.000498591653125711,0.0157631668795898
27,WP_PDGF_PATHWAY,37,Down,0.000603520690123288,0.0183738521215312
28,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,76,Down,0.000677807315867529,0.0198984862015396
29,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,30,Down,0.000716785178129229,0.0203171522904216
30,WP_INTEGRINMEDIATED_CELL_ADHESION,72,Down,0.000770739564197857,0.0211182640590213
31,WP_CHEMOKINE_SIGNALING,109,Down,0.000872580587496878,0.0231374594491108
32,WP_POSTCOVID_NEUROINFLAMMATION,12,Down,0.000949267111889886,0.0236566172074662
33,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Down,0.000949718209058861,0.0236566172074662
34,WP_TAMOXIFEN_METABOLISM,2,Up,0.00100726664598151,0.0243521524410824
35,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,0.00104443145814889,0.0245292188170968
36,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,42,Down,0.00110323015174271,0.0251904217981253
37,WP_HEART_DEVELOPMENT,17,Down,0.00116887815827841,0.0259680498947257
38,WP_ASPIRIN_AND_MIRNAS,8,Down,0.00120383387447557,0.0260408274952347
39,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.00136064953030877,0.0286783054849694
40,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,93,Down,0.0014294257292144,0.0293746987353559
41,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,47,Down,0.00158041187213459,0.0316853307047472
42,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,106,Down,0.00168177772680633,0.0329147926532096
43,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Down,0.00180594543051662,0.0345229568345271
44,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Down,0.0019198260124162,0.0358658405046845
45,WP_REGULATION_OF_ACTIN_CYTOSKELETON,92,Down,0.00207596938162553,0.0379210407043597
46,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,33,Down,0.00215159951030638,0.0384481477711271
47,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,48,Down,0.00232702551829182,0.0400080677032136
48,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Down,0.00233846698452418,0.0400080677032136
49,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.00238490914532539,0.0400080677032136
50,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,42,Down,0.0028312674642732,0.0465460371126514
51,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.00291166153711414,0.0469291330099573
52,WP_NEUROINFLAMMATION,10,Down,0.00299418803781905,0.0473312032132166
53,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,15,Down,0.00340045549891333,0.0519883266514527
54,WP_G13_SIGNALING,30,Down,0.00347226046350826,0.0519883266514527
55,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Down,0.00347853767132591,0.0519883266514527
56,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,64,Down,0.00357312230125482,0.0524483309219903
57,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,41,Down,0.00426409374800415,0.0614927203659546
58,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,70,Down,0.00441474272642274,0.0625675607089568
59,WP_FOCAL_ADHESION,121,Down,0.00461746647120957,0.0643314820226147
60,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,16,Down,0.00477859596000178,0.0654667646520244
61,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,53,Down,0.0048677071527652,0.0655943488454589
62,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,17,Down,0.00511965295348029,0.0678766891574322
63,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Up,0.00552269505009463,0.0699846421899613
64,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,33,Down,0.00552301812611646,0.0699846421899613
65,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,57,Down,0.0056358638199865,0.0699846421899613
66,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,14,Down,0.00564175465178977,0.0699846421899613
67,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,28,Down,0.00570434431475353,0.0699846421899613
68,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,30,Down,0.00586991165521155,0.0703249730386773
69,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,12,Down,0.00590319116748021,0.0703249730386773
70,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,62,Down,0.00608703732374061,0.0714792097159254
71,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.00715937959980273,0.0828874652258851
72,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Down,0.00769775671980854,0.0878827225511475
73,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.00803443464754414,0.090469935346319
74,WP_VEGFAVEGFR2_SIGNALING,344,Down,0.00820262852054405,0.0905232601377886
75,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,46,Down,0.00825942154541867,0.0905232601377886
76,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Down,0.00866689494661573,0.0937393111331333
77,WP_ONCOSTATIN_M_SIGNALING,55,Down,0.00904398721890779,0.0959291873285086
78,WP_MAPK_SIGNALING,165,Down,0.00910276960051542,0.0959291873285086
79,WP_CREATINE_PATHWAY,2,Down,0.00942662214240656,0.0976414110872587
80,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,24,Down,0.00986204317579985,0.0976414110872587
81,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.00987428254208651,0.0976414110872587
82,WP_EGFEGFR_SIGNALING,141,Down,0.0100045041335429,0.0976414110872587
83,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,44,Down,0.0100662634169544,0.0976414110872587
84,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,13,Down,0.010123218471067,0.0976414110872587
85,WP_SPHINGOLIPID_PATHWAY,20,Down,0.0101824696225577,0.0976414110872587
86,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Down,0.0103128901729234,0.0976414110872587
87,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.0103343099325931,0.0976414110872587
88,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Down,0.0107314328497426,0.100241338664641
89,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Down,0.0111154330747141,0.102382881225169
90,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Down,0.0113237521036071,0.102382881225169
91,WP_HEPATITIS_B_INFECTION,119,Down,0.0113343578971903,0.102382881225169
92,WP_EBOLA_VIRUS_INFECTION_IN_HOST,106,Down,0.0123420118820185,0.110273193119774
93,WP_BURN_WOUND_HEALING,61,Down,0.0129073348450421,0.113911146332352
94,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.0130263354686631,0.113911146332352
95,WP_CARDIAC_HYPERTROPHIC_RESPONSE,45,Down,0.0134517103066625,0.115045346497203
96,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.0135639875382828,0.115045346497203
97,WP_PROXIMAL_TUBULE_TRANSPORT,25,Down,0.0136614707341591,0.115045346497203
98,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,22,Down,0.0137158685604938,0.115045346497203
99,WP_AGERAGE_PATHWAY,54,Down,0.0138891866494924,0.115322337635179
100,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Down,0.0142741326501334,0.116816701854153
101,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Down,0.0143751240371663,0.116816701854153
102,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,49,Down,0.0144955031497854,0.116816701854153
103,WP_ERBB_SIGNALING,69,Down,0.0146630476269261,0.117019661644012
104,WP_TNFALPHA_SIGNALING,85,Down,0.0148581380837527,0.117436437546584
105,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Down,0.0152458003414168,0.118585408093222
106,WP_PDGFRBETA_PATHWAY,28,Down,0.0153483157471003,0.118585408093222
107,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,21,Down,0.0154363000802613,0.118585408093222
108,WP_SYNAPTIC_VESICLE_PATHWAY,22,Down,0.0167442120242363,0.12589588177936
109,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,17,Down,0.0168171761932461,0.12589588177936
110,WP_RAC1PAK1P38MMP2_PATHWAY,52,Down,0.0168473807733937,0.12589588177936
111,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,19,Down,0.0170266819930816,0.126089482867686
112,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.0172180929963645,0.126368503955461
113,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,19,Down,0.0174444249403131,0.126896613282632
114,WP_CCL18_SIGNALING,21,Down,0.0176854591574477,0.126911147221775
115,WP_NOTCH_SIGNALING_WP268,35,Down,0.0177552091611973,0.126911147221775
116,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.0181053057726088,0.128297942630038
117,WP_NEURAL_CREST_DIFFERENTIATION,41,Down,0.0189741186982407,0.133305346751742
118,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.0194580198265339,0.134572197936399
119,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,22,Down,0.0198817544296154,0.134572197936399
120,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.0199511417405243,0.134572197936399
121,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,37,Down,0.0199845069057167,0.134572197936399
122,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,32,Down,0.0200990529902525,0.134572197936399
123,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,46,Down,0.0201777844146598,0.134572197936399
124,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,9,Up,0.0203004288857828,0.134572197936399
125,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.0205167322821507,0.134918031487423
126,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.0214374567136144,0.139173263264807
127,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,50,Down,0.0215024384849519,0.139173263264807
128,WP_OVARIAN_INFERTILITY,22,Down,0.0223724078138037,0.142646385319183
129,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,29,Down,0.0223861115646894,0.142646385319183
130,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Up,0.0233162145215088,0.147430217974464
131,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,29,Down,0.0238278287800777,0.149296574926392
132,WP_WNT_SIGNALING_WP363,38,Down,0.0241430368623479,0.149296574926392
133,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,73,Down,0.0241723275560859,0.149296574926392
134,WP_CHOLESTEROL_METABOLISM,54,Down,0.0243378844770517,0.149296574926392
135,WP_PLEURAL_MESOTHELIOMA,256,Down,0.0249005865108911,0.151616904532982
136,WP_NEOVASCULARIZATION_PROCESSES,22,Down,0.0253507460787279,0.153222891740547
137,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.0260535066286583,0.156098551692895
138,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Down,0.0262063261966175,0.156098551692895
139,WP_KETOGENESIS_AND_KETOLYSIS,6,Up,0.0264875036893717,0.156638331170241
140,WP_TGFB_SMAD_SIGNALING,7,Down,0.0267869918526168,0.157277909306079
141,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.027307792417964,0.158510212447178
142,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,8,Down,0.0274252292517344,0.158510212447178
143,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,25,Down,0.0276529654016835,0.158510212447178
144,WP_VITAMIN_D_RECEPTOR_PATHWAY,86,Down,0.0280643186374435,0.158510212447178
145,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.0282482707206616,0.158510212447178
146,WP_THERMOGENESIS,74,Down,0.0283546089692683,0.158510212447178
147,WP_LUNG_FIBROSIS,33,Down,0.0283741307075977,0.158510212447178
148,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.0285395516328252,0.158510212447178
149,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Down,0.0295214448363814,0.162863272855742
150,WP_GPCRS_CLASS_A_RHODOPSINLIKE,43,Down,0.0302321609567956,0.16567224204324
151,WP_SULFATASE_AND_AROMATASE_PATHWAY,3,Up,0.0309229979895314,0.168335790380098
152,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.0313315945341215,0.168633543490482
153,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,61,Down,0.03177384299768,0.168633543490482
154,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Down,0.0319020150967419,0.168633543490482
155,WP_INSULIN_SIGNALING,132,Down,0.0319493101990623,0.168633543490482
156,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,61,Down,0.0320034462098724,0.168633543490482
157,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,89,Down,0.032451177340738,0.169903616395456
158,WP_TOLLLIKE_RECEPTOR_SIGNALING,80,Down,0.03285718100148,0.170940523944408
159,WP_PURINERGIC_SIGNALING,16,Down,0.0335696578286814,0.172752296863231
160,WP_TARGET_OF_RAPAMYCIN_SIGNALING,33,Down,0.0336257512142542,0.172752296863231
161,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,48,Down,0.033860319106116,0.17287690872812
162,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,9,Up,0.0344432183355412,0.174767441184042
163,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Down,0.0347176301638111,0.175079091991734
164,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Down,0.0359802855350313,0.180340211645096
165,WP_OREXIN_RECEPTOR_PATHWAY,118,Down,0.0374676185074386,0.186269150910748
166,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Down,0.0376163978724868,0.186269150910748
167,WP_CELL_DIFFERENTIATION_INDEX,7,Down,0.0380745312557955,0.187408770612359
168,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,5,Down,0.0385052868954562,0.188400868024196
169,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,15,Down,0.039054236985898,0.189956111256853
170,WP_GPCRS_OTHER,15,Down,0.0396908709287706,0.191150573485722
171,WP_RALA_DOWNSTREAM_REGULATED_GENES,12,Down,0.0397649003236722,0.191150573485722
172,WP_BENZENE_METABOLISM,4,Up,0.0403120838249321,0.192654261070315
173,WP_DNA_REPLICATION,36,Up,0.0417630725514384,0.196345847281066
174,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Down,0.0418156910972296,0.196345847281066
175,WP_IL3_SIGNALING,46,Down,0.0421756788993209,0.196345847281066
176,WP_NEPHROTIC_SYNDROME,27,Down,0.0421774712950867,0.196345847281066
177,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,87,Down,0.042278850326945,0.196345847281066
178,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,24,Down,0.04348175483273,0.200762820927525
179,WP_MONOAMINE_GPCRS,3,Down,0.0439023798492406,0.200762820927525
180,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Down,0.0439626615169763,0.200762820927525
181,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Down,0.0447481895370647,0.203221059665564
182,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Down,0.045566434021846,0.205800048164601
183,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Down,0.0464713518646146,0.208740170670564
184,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Down,0.04756498214363,0.212436778313064
185,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,9,Down,0.0478111970655922,0.212436778313064
186,WP_BENZOAPYRENE_METABOLISM,5,Up,0.0482676435388519,0.213311844026539
187,WP_AXON_GUIDANCE,38,Down,0.0490201352414869,0.214720128599198
188,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Down,0.049108739874269,0.214720128599198
189,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.0494542567142596,0.215086767296939
190,WP_ARYLAMINE_METABOLISM,1,Up,0.0508201612002957,0.219864065824437
191,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.0515816172013323,0.221989996541859
192,WP_CAMKK2_PATHWAY,30,Down,0.0521346664292175,0.222102120541584
193,WP_NETRINUNC5B_SIGNALING,35,Down,0.052358532390463,0.222102120541584
194,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,13,Down,0.0524182620256294,0.222102120541584
195,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,3,Down,0.0529791440213936,0.223327468644028
196,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,33,Down,0.0533965276318136,0.223938498537504
197,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Down,0.0568195965319223,0.237084813955534
198,WP_B_CELL_RECEPTOR_SIGNALING,87,Down,0.0581450961412925,0.241242723574212
199,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,20,Down,0.0584030437849978,0.241242723574212
200,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,4,Down,0.0597086196728613,0.24540242685546
201,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Up,0.0601483062215157,0.245979640368586
202,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,21,Down,0.0613106223717341,0.249491740542403
203,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,6,Down,0.0630619468561801,0.255354287269852
204,WP_NGLYCAN_BIOSYNTHESIS,52,Down,0.0640440347512226,0.257888827200707
205,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,21,Down,0.0647374029354829,0.257888827200707
206,WP_COMPLEMENT_AND_COAGULATION_CASCADES,25,Up,0.0649428068498131,0.257888827200707
207,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,25,Up,0.0649428068498131,0.257888827200707
208,WP_GASTRIC_CANCER_NETWORK_2,26,Down,0.0656955197826891,0.259623640679666
209,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Down,0.0681299904185137,0.267956230258461
210,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Down,0.0686775843370303,0.268615682596084
211,WP_ESTROGEN_METABOLISM_WP5276,9,Up,0.0692198458380319,0.268615682596084
212,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.0692780105965569,0.268615682596084
213,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Up,0.0700508419386247,0.270337051988495
214,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,17,Down,0.0704067076806763,0.270338101441259
215,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Down,0.070965913880066,0.270338101441259
216,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Down,0.0710914822007499,0.270338101441259
217,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,49,Up,0.071366627752741,0.270338101441259
218,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,35,Down,0.0718054960360908,0.27075283367737
219,WP_WNT_SIGNALING_WP428,60,Down,0.0721594268003383,0.270844971825927
220,WP_SEROTONIN_AND_ANXIETY,8,Down,0.072663847990733,0.27149855931083
221,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Down,0.0743534885160156,0.276554604344637
222,WP_MAPK_CASCADE,30,Down,0.0758432497050296,0.278427200914191
223,WP_GLUTATHIONE_METABOLISM,11,Down,0.0758905756125991,0.278427200914191
224,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Down,0.0761097511417704,0.278427200914191
225,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,56,Down,0.0762118250677531,0.278427200914191
226,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,137,Down,0.0778682183563438,0.283219803048295
227,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.0782722562254042,0.283435218578336
228,WP_LEPTIN_SIGNALING,70,Down,0.0803864825569467,0.289814423955308
229,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Down,0.0816909970235112,0.292569417904051
230,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.0819368014678132,0.292569417904051
231,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,18,Down,0.0822184130606274,0.292569417904051
232,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Down,0.0836116585043234,0.296244755562732
233,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.0848050614705327,0.298153150656371
234,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,19,Down,0.0848757144204268,0.298153150656371
235,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Down,0.0861344938029747,0.301287463429979
236,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,21,Down,0.0870668417158174,0.303258236823737
237,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Down,0.0875258153711523,0.303570549515136
238,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,5,Down,0.0885445239747957,0.304660604195103
239,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Down,0.0885813678864109,0.304660604195103
240,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,80,Down,0.0892061636580447,0.305531110528803
241,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,12,Down,0.0911646247271869,0.307858771147049
242,WP_16P112_DISTAL_DELETION_SYNDROME,22,Up,0.0914339400227938,0.307858771147049
243,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,9,Down,0.0915121858341991,0.307858771147049
244,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,27,Down,0.0920782075798268,0.307858771147049
245,WP_GABA_RECEPTOR_SIGNALING,10,Down,0.0922177273178115,0.307858771147049
246,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.0924520030888093,0.307858771147049
247,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Down,0.0925074409651108,0.307858771147049
248,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,48,Down,0.0940846774410041,0.311845180873006
249,WP_HIPPO_SIGNALING_REGULATION,45,Down,0.0951348380387902,0.314059585814801
250,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Down,0.0971313961262706,0.319368030463178
251,WP_IL18_SIGNALING,192,Down,0.098851284827055,0.321963288047709
252,WP_RANKLRANK_SIGNALING,48,Down,0.0990910014633142,0.321963288047709
253,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,40,Down,0.0990957565402315,0.321963288047709
254,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Down,0.103481830528543,0.334187047224431
255,WP_6Q16_COPY_NUMBER_VARIATION,5,Up,0.103863927045429,0.334187047224431
256,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Down,0.104736037505241,0.334187047224431
257,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Down,0.105116650122774,0.334187047224431
258,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,24,Down,0.105458253236739,0.334187047224431
259,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Down,0.105590438885357,0.334187047224431
260,WP_GPCRS_CLASS_B_SECRETINLIKE,5,Down,0.105960430455775,0.334187047224431
261,WP_MONOAMINE_TRANSPORT,12,Down,0.106110485797538,0.334187047224431
262,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Down,0.106704738103681,0.334314163383702
263,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,87,Down,0.106964263953666,0.334314163383702
264,WP_IRINOTECAN_PATHWAY,5,Up,0.108544529819518,0.33694365350031
265,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,77,Down,0.108625387077351,0.33694365350031
266,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Down,0.10989793878892,0.339609419866514
267,WP_RAS_SIGNALING,119,Down,0.112757365787142,0.347140654221088
268,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,24,Down,0.114443361296487,0.350448830203982
269,WP_ATR_SIGNALING,10,Up,0.114684592852641,0.350448830203982
270,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Down,0.116016689162449,0.353206364783454
271,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Down,0.11659640252295,0.353661412818689
272,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,74,Down,0.118029831766465,0.356693094529537
273,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Down,0.120810658440774,0.363583906853901
274,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,19,Down,0.12123491354631,0.363583906853901
275,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,20,Down,0.121636951806354,0.363583906853901
276,WP_TCELL_RECEPTOR_SIGNALING,73,Down,0.122768722296898,0.365610972464663
277,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,177,Down,0.123291018024293,0.365610972464663
278,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,0.12368902472202,0.365610972464663
279,WP_PURINE_METABOLISM,10,Down,0.124094235179612,0.365610972464663
280,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.12557611954724,0.368655608099398
281,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,14,Down,0.126509637005619,0.370074454158786
282,WP_DISORDERS_IN_KETOLYSIS,4,Down,0.12768360320416,0.372184119978083
283,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,74,Down,0.128165343954017,0.372268242862906
284,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Down,0.128921598800622,0.373146317655323
285,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Down,0.130519212010131,0.376444885166061
286,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,45,Up,0.132956100388267,0.382132568248794
287,WP_BLADDER_CANCER,29,Down,0.134620805262329,0.385568996256565
288,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Down,0.136431097343719,0.389397090335198
289,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Up,0.137515046398367,0.391132761728228
290,WP_OSTEOBLAST_SIGNALING,3,Down,0.139931870792104,0.394223893256598
291,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Down,0.139936077556187,0.394223893256598
292,WP_BASE_EXCISION_REPAIR,29,Up,0.140040604417186,0.394223893256598
293,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,45,Down,0.142037493697241,0.398480613717174
294,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Up,0.143109685941552,0.399181024981894
295,WP_SLEEP_REGULATION,11,Up,0.143355975315302,0.399181024981894
296,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,6,Up,0.143744018728273,0.399181024981894
297,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,20,Down,0.145344452893526,0.402266465584102
298,WP_NPHP1_DELETION_SYNDROME,10,Down,0.146611078867993,0.404410425602318
299,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.147838350595475,0.406431853476524
300,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Down,0.148774548698259,0.407642263433231
301,WP_PROLACTIN_SIGNALING,69,Down,0.151967530509525,0.414765350676082
302,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.15238337701238,0.414765350676082
303,WP_DNA_MISMATCH_REPAIR,21,Up,0.154409387867064,0.416787469871897
304,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.154616086410361,0.416787469871897
305,WP_OXIDATION_BY_CYTOCHROME_P450,15,Down,0.155117379021434,0.416787469871897
306,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.155154459587349,0.416787469871897
307,WP_IL19_SIGNALING,20,Down,0.162200405919697,0.43092596907868
308,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,58,Up,0.162679098374455,0.43092596907868
309,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,15,Down,0.162753592199047,0.43092596907868
310,WP_AFLATOXIN_B1_METABOLISM,3,Up,0.163079183488972,0.43092596907868
311,WP_DOPAMINERGIC_NEUROGENESIS,4,Down,0.163397920927747,0.43092596907868
312,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,38,Down,0.164069928288136,0.43092596907868
313,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,8,Down,0.164501145151192,0.43092596907868
314,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Down,0.164611623224703,0.43092596907868
315,WP_ANGIOGENESIS,14,Down,0.168793000655463,0.440469354091399
316,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,85,Down,0.172364912344737,0.448366955529663
317,WP_LUNG_PATHOLOGY_OF_COVID19,15,Down,0.173945738265067,0.45105172509112
318,WP_NONHOMOLOGOUS_END_JOINING,10,Up,0.17604757248884,0.455066366622097
319,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,113,Up,0.176884317129563,0.455795951976492
320,WP_LIPID_PARTICLES_COMPOSITION,6,Up,0.178459470568489,0.458417765022806
321,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,7,Down,0.179826415379397,0.46038999744698
322,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,24,Up,0.181077597415755,0.46038999744698
323,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Down,0.18204245525837,0.46038999744698
324,WP_NOTCH_SIGNALING_WP61,49,Down,0.18223238843762,0.46038999744698
325,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,169,Down,0.18240729918955,0.46038999744698
326,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Up,0.182889304753433,0.46038999744698
327,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,39,Up,0.183147845699711,0.46038999744698
328,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Down,0.185982093099127,0.466089269900862
329,WP_CANCER_PATHWAYS,311,Down,0.187790990136321,0.468466197785667
330,WP_THIAMINE_METABOLIC_PATHWAYS,9,Up,0.188070371373808,0.468466197785667
331,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,31,Down,0.188844047991497,0.468601242562185
332,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,63,Up,0.189443570986881,0.468601242562185
333,WP_ENDOMETRIAL_CANCER,49,Down,0.189834809943075,0.468601242562185
334,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,93,Down,0.192579991851026,0.473954351202225
335,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.194377989056134,0.47695136419147
336,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Up,0.195901996306619,0.479260240964408
337,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.196926351740192,0.480336679912279
338,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Down,0.199231645259974,0.483964022882422
339,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.199591002137641,0.483964022882422
340,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.201298003622992,0.485654785256657
341,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,25,Down,0.20146992916365,0.485654785256657
342,WP_UROTENSINIIMEDIATED_SIGNALING,49,Down,0.202365708638357,0.486387755850086
343,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Down,0.204330644455755,0.488768133154751
344,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,23,Up,0.204586031701186,0.488768133154751
345,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,26,Down,0.205140688583789,0.488768133154751
346,WP_FLUOROACETIC_ACID_TOXICITY,6,Up,0.205861520279713,0.488768133154751
347,WP_OSTEOCLAST_SIGNALING,9,Down,0.206526805419868,0.488768133154751
348,WP_SELENIUM_MICRONUTRIENT_NETWORK,51,Down,0.206923735204201,0.488768133154751
349,WP_HISTONE_MODIFICATIONS,37,Up,0.208576370824302,0.490340365656576
350,WP_RETT_SYNDROME,33,Down,0.209245912956665,0.490340365656576
351,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Down,0.209378915262115,0.490340365656576
352,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Down,0.212924871688762,0.497227967409551
353,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,33,Down,0.21374746141834,0.497734881829677
354,WP_PAFAH1B1_COPY_NUMBER_VARIATION,9,Down,0.215671100947139,0.499381782115261
355,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,56,Down,0.216028566317075,0.499381782115261
356,WP_NAD_METABOLISM,12,Down,0.216577102695033,0.499381782115261
357,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.216884788582906,0.499381782115261
358,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,16,Down,0.218687530814011,0.500582761820804
359,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Down,0.21994058337116,0.500582761820804
360,WP_IDO_METABOLIC_PATHWAY,7,Down,0.220058520097809,0.500582761820804
361,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,63,Up,0.220643191612421,0.500582761820804
362,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,42,Down,0.220914381577948,0.500582761820804
363,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,52,Down,0.221283351969674,0.500582761820804
364,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,9,Down,0.221669252193154,0.500582761820804
365,WP_G_PROTEIN_SIGNALING,62,Down,0.223138080160633,0.502168898751766
366,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Down,0.223593451269035,0.502168898751766
367,WP_DRAVET_SYNDROME,15,Down,0.224583040293764,0.503017054826906
368,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,4,Down,0.226907914848589,0.505168990770738
369,WP_TGFBETA_RECEPTOR_SIGNALING,36,Down,0.227002107337372,0.505168990770738
370,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.228053369098178,0.505168990770738
371,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,10,Down,0.228105905447499,0.505168990770738
372,WP_PRION_DISEASE_PATHWAY,28,Down,0.22861662356048,0.505168990770738
373,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.230534837442881,0.50804192058458
374,WP_FRAGILE_X_SYNDROME,84,Down,0.23274524712425,0.511541692877361
375,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Up,0.234731013503553,0.514530381599788
376,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,66,Down,0.235564693244809,0.514984515551152
377,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.238786777730042,0.520643849586458
378,WP_DOPAMINE_METABOLISM,7,Up,0.242263178516647,0.52553667332185
379,WP_IL5_SIGNALING,37,Down,0.242309488064454,0.52553667332185
380,WP_WNT_SIGNALING_AND_PLURIPOTENCY,61,Down,0.244380689140107,0.528634017034652
381,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,22,Down,0.245659027585751,0.529934543161456
382,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Up,0.246271284048268,0.529934543161456
383,WP_7OXOC_AND_7BETAHC_PATHWAYS,17,Down,0.247872157279955,0.5319867187575
384,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,31,Down,0.249362345307424,0.533791270423705
385,WP_GLYCOLYSIS_IN_SENESCENCE,11,Down,0.254111576702504,0.541598396702499
386,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Down,0.254327227648619,0.541598396702499
387,WP_VITAMIN_D_METABOLISM,6,Down,0.255258324641357,0.541889188306096
388,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Down,0.256056348775054,0.541889188306096
389,WP_TYPE_II_DIABETES_MELLITUS,14,Down,0.256441477191085,0.541889188306096
390,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,12,Up,0.258483444750123,0.544803568165644
391,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Down,0.260102082910693,0.546813074559052
392,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Down,0.262904912678353,0.550372178417383
393,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,29,Down,0.263134143695902,0.550372178417383
394,WP_PARKINSONS_DISEASE_PATHWAY,27,Down,0.265382909897554,0.55366688308576
395,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.266610640487204,0.554820117672106
396,WP_GLIOBLASTOMA_SIGNALING,68,Down,0.26832808269259,0.556984050437648
397,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Down,0.269035949801542,0.557046727296896
398,WP_VITAMIN_B12_DISORDERS,9,Down,0.271177044704031,0.557415357820679
399,WP_COMPLEMENT_SYSTEM,52,Up,0.27199656299197,0.557415357820679
400,WP_SMALL_CELL_LUNG_CANCER,69,Down,0.272277596519926,0.557415357820679
401,WP_TCA_CYCLE_IN_SENESCENCE,10,Up,0.274032156204935,0.557415357820679
402,WP_HIPPOYAP_SIGNALING,16,Down,0.274123393879969,0.557415357820679
403,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Down,0.274464089312091,0.557415357820679
404,WP_BLOOD_CLOTTING_CASCADE,6,Down,0.27482792727944,0.557415357820679
405,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,39,Down,0.275327781806055,0.557415357820679
406,WP_ENDOCHONDRAL_OSSIFICATION,26,Down,0.275995195417295,0.557415357820679
407,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,26,Down,0.275995195417295,0.557415357820679
408,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Down,0.278231585858678,0.560554812685866
409,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Down,0.282451795998433,0.567628053250803
410,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,10,Down,0.283123481548454,0.567628053250803
411,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.285805663406362,0.571611326812725
412,WP_KIT_RECEPTOR_SIGNALING,52,Down,0.289611587596795,0.576528594667769
413,WP_IL4_SIGNALING,51,Down,0.289667043306312,0.576528594667769
414,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Up,0.292744252205433,0.578710308821574
415,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Up,0.293058779945746,0.578710308821574
416,WP_ESTROGEN_METABOLISM_WP697,6,Up,0.293585201316814,0.578710308821574
417,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,9,Down,0.293862349326473,0.578710308821574
418,WP_ADIPOGENESIS,86,Down,0.295102542378799,0.578710308821574
419,WP_BDNFTRKB_SIGNALING,27,Down,0.296569966456745,0.578710308821574
420,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.296715548315327,0.578710308821574
421,WP_MELANOMA,54,Down,0.296751491636458,0.578710308821574
422,WP_ALANINE_AND_ASPARTATE_METABOLISM,6,Down,0.297099452947329,0.578710308821574
423,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Up,0.300960674057907,0.58321270415451
424,WP_ENERGY_METABOLISM,41,Down,0.301203857439251,0.58321270415451
425,WP_FATTY_ACID_TRANSPORTERS,10,Down,0.301937777178688,0.58321270415451
426,WP_NUCLEAR_RECEPTORS,20,Down,0.302722510244169,0.58321270415451
427,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Down,0.303424565303137,0.58321270415451
428,WP_ENDODERM_DIFFERENTIATION,84,Down,0.303667928683857,0.58321270415451
429,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,13,Down,0.304669325970951,0.583771995217068
430,WP_HUNGER_AND_SATIETY,2,Up,0.30643006469079,0.584749688702111
431,WP_RETINOL_METABOLISM,6,Down,0.306602330694172,0.584749688702111
432,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,46,Down,0.308576679936099,0.586234520436029
433,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.308994047161811,0.586234520436029
434,WP_SULINDAC_METABOLIC_PATHWAY,2,Up,0.310183900642527,0.586234520436029
435,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,23,Down,0.310343295850024,0.586234520436029
436,WP_TROP2_REGULATORY_SIGNALING,42,Down,0.310946777262906,0.586234520436029
437,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Down,0.31257608010238,0.58795775250379
438,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.313499211866912,0.588347835969411
439,WP_G1_TO_S_CELL_CYCLE_CONTROL,51,Up,0.315334601503544,0.590444288008914
440,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Up,0.316108089963161,0.590547386249359
441,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,78,Down,0.318103640948117,0.592927874964518
442,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.321608772121734,0.59810500154766
443,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Down,0.324033525405633,0.599675652131465
444,WP_CYTOSINE_METHYLATION,7,Down,0.324935148101899,0.599675652131465
445,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.325008840290166,0.599675652131465
446,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,10,Up,0.325383459178689,0.599675652131465
447,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Down,0.326128652014756,0.599675652131465
448,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Down,0.326830525735884,0.599675652131465
449,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.328662716717659,0.600751679656182
450,WP_METASTATIC_BRAIN_TUMOR,5,Down,0.329411766468015,0.600751679656182
451,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Up,0.330090321936042,0.600751679656182
452,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,21,Down,0.331049382563736,0.600751679656182
453,WP_ETHER_LIPID_BIOSYNTHESIS,16,Up,0.331626134057288,0.600751679656182
454,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,10,Down,0.331802022583828,0.600751679656182
455,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,41,Down,0.333851416389145,0.6031337676305
456,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.336417241914252,0.606436343977007
457,WP_RETINOBLASTOMA_GENE_IN_CANCER,74,Up,0.337746559994931,0.607193497583441
458,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,38,Down,0.338314625174228,0.607193497583441
459,WP_PREIMPLANTATION_EMBRYO,21,Down,0.340752014583899,0.609485132235486
460,WP_JOUBERT_SYNDROME,72,Up,0.341074404900637,0.609485132235486
461,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,48,Down,0.34227305815888,0.610300333636875
462,WP_OPIOID_RECEPTOR_PATHWAYS,25,Down,0.343134372832202,0.610511806207943
463,WP_INTEGRATED_CANCER_PATHWAY,41,Down,0.344024566644655,0.610773636677983
464,WP_OMEGA9_FATTY_ACID_SYNTHESIS,11,Down,0.349631736665921,0.619390705903851
465,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Down,0.351946571290521,0.622150713120018
466,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.353379486466371,0.623343214324801
467,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Down,0.354409466123284,0.623821372919356
468,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,12,Up,0.36106962984302,0.631688160517899
469,WP_MELATONIN_METABOLISM_AND_EFFECTS,19,Up,0.361442388634134,0.631688160517899
470,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Up,0.361813937013522,0.631688160517899
471,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Down,0.361952705114271,0.631688160517899
472,WP_AUTOPHAGY,27,Down,0.363524701955219,0.632147865997219
473,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,62,Down,0.364469652613399,0.632147865997219
474,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Down,0.364523221998396,0.632147865997219
475,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.366068104947018,0.632213278249011
476,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Down,0.366099173292614,0.632213278249011
477,WP_GLUCURONIDATION,7,Up,0.367004690806254,0.632448335100085
478,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Down,0.368255304323591,0.633275858062745
479,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,278,Down,0.371916453472333,0.638236586125799
480,WP_NONSMALL_CELL_LUNG_CANCER,60,Down,0.375440867051746,0.642685646890948
481,WP_ANDROGEN_RECEPTOR_SIGNALING,77,Down,0.376094432704733,0.642685646890948
482,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.37746464592093,0.642685646890948
483,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.377636456749791,0.642685646890948
484,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,5,Down,0.379058723623191,0.643773286814594
485,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Down,0.380738556000477,0.64529297532452
486,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,14,Down,0.382535961536123,0.647005268277146
487,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Up,0.384236540651247,0.64793448608342
488,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.384853157453503,0.64793448608342
489,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Down,0.386880740962193,0.64793448608342
490,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.387066108989169,0.64793448608342
491,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Up,0.387631389569544,0.64793448608342
492,WP_NUCLEOTIDE_GPCRS,6,Down,0.389282742015001,0.64793448608342
493,WP_TYPE_III_INTERFERON_SIGNALING,7,Down,0.389548745031059,0.64793448608342
494,WP_SPINA_BIFIDA,10,Up,0.390080888051536,0.64793448608342
495,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,12,Up,0.390179526291111,0.64793448608342
496,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Up,0.396747421403989,0.656292275113984
497,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,6,Down,0.396809319624878,0.656292275113984
498,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,3,Up,0.399591197358302,0.659566193229968
499,WP_CHOLESTASIS,9,Up,0.403434117515782,0.664574838873692
500,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.406289235055808,0.667939502431749
501,WP_FOXP3_IN_COVID19,9,Down,0.410543065106844,0.673585627780091
502,WP_GLYOXYLATE_METABOLISM,5,Up,0.412728052387825,0.674641544153786
503,WP_HOMOLOGOUS_RECOMBINATION,11,Up,0.413828147431261,0.674641544153786
504,WP_LIVER_X_RECEPTOR_PATHWAY,5,Up,0.414431332481346,0.674641544153786
505,WP_PI3KAKT_SIGNALING,180,Down,0.414469561797642,0.674641544153786
506,WP_IL7_SIGNALING,23,Down,0.41548336250869,0.674955185735461
507,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,20,Up,0.417476808294772,0.675465354657864
508,WP_FERROPTOSIS,51,Down,0.417880209701294,0.675465354657864
509,WP_IL2_SIGNALING,37,Down,0.41857421796222,0.675465354657864
510,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,66,Down,0.419542471930582,0.675465354657864
511,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.419906078138891,0.675465354657864
512,WP_EFFECTS_OF_MFN2_MUTATION,17,Down,0.422434614381283,0.677799631479478
513,WP_KREBS_CYCLE_DISORDERS,12,Up,0.423006339353981,0.677799631479478
514,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Up,0.428869354228129,0.685857216294789
515,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,17,Down,0.42978573721383,0.685988108717997
516,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Down,0.432209357855143,0.687707858007132
517,WP_P38_MAPK_SIGNALING,31,Down,0.432536450839036,0.687707858007132
518,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,52,Down,0.435572874721223,0.691198654480396
519,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Down,0.436432826647305,0.691228869950067
520,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.439336672602393,0.694489893998399
521,WP_ACE_INHIBITOR_PATHWAY,5,Down,0.440761475545582,0.695404861609345
522,WP_IRON_METABOLISM_DISORDERS,10,Up,0.442199937864626,0.696337833189124
523,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,7,Down,0.445018651610498,0.69778137746821
524,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,11,Up,0.445595619577045,0.69778137746821
525,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Up,0.445663288528966,0.69778137746821
526,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,11,Up,0.452051123972034,0.705450544184742
527,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Up,0.455730908984169,0.705450544184742
528,WP_BREAST_CANCER_PATHWAY,87,Down,0.455832859270517,0.705450544184742
529,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,90,Up,0.455997078365118,0.705450544184742
530,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Down,0.45618243829891,0.705450544184742
531,WP_TAR_SYNDROME,44,Down,0.45620308197485,0.705450544184742
532,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,13,Up,0.4569271491314,0.705450544184742
533,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Down,0.457427177676968,0.705450544184742
534,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.459149004140005,0.706779927721132
535,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,30,Down,0.460733268366215,0.707879598831028
536,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,37,Down,0.46158572381196,0.707879598831028
537,WP_INFLAMMATORY_RESPONSE_PATHWAY,14,Up,0.466251641359189,0.713703629790043
538,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Up,0.467509702573165,0.714152678502304
539,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Up,0.468282595757593,0.714152678502304
540,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.470164500391961,0.714625241791805
541,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,18,Up,0.471200932855216,0.714625241791805
542,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,69,Down,0.471749370550276,0.714625241791805
543,WP_TRANSSULFURATION_PATHWAY,8,Up,0.472073521950274,0.714625241791805
544,WP_CILIOPATHIES,129,Up,0.472939332767326,0.714625241791805
545,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Down,0.47534867424288,0.716754470685773
546,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,49,Down,0.476092385637995,0.716754470685773
547,WP_ONECARBON_METABOLISM,23,Up,0.47820026788991,0.718611737121584
548,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,25,Up,0.48046168580131,0.719843988668907
549,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,10,Up,0.48077171505989,0.719843988668907
550,WP_PHOSPHOINOSITIDES_METABOLISM,39,Down,0.486370259573871,0.725234205227132
551,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,11,Down,0.487369854722386,0.725234205227132
552,WP_OSTEOPONTIN_SIGNALING,11,Down,0.487399971249363,0.725234205227132
553,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Down,0.487900870426526,0.725234205227132
554,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Down,0.489618818161136,0.726474130917787
555,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Down,0.49288341649463,0.72874075248782
556,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Up,0.493497997033803,0.72874075248782
557,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Down,0.49380608167362,0.72874075248782
558,WP_IL11_SIGNALING,41,Down,0.495176011471953,0.729452834103845
559,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Down,0.498613036104205,0.732748574109364
560,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,18,Down,0.499196108882292,0.732748574109364
561,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,5,Down,0.50535085740273,0.737988205141983
562,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,82,Down,0.505830164256517,0.737988205141983
563,WP_TRIACYLGLYCERIDE_SYNTHESIS,18,Up,0.506194455645898,0.737988205141983
564,WP_KCNQ2RELATED_EPILEPSIES,11,Up,0.507626173485578,0.737988205141983
565,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,29,Down,0.508081100564523,0.737988205141983
566,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Down,0.508152462421365,0.737988205141983
567,WP_MITOCHONDRIAL_BETAOXIDATION,8,Down,0.510464718712484,0.738803324226921
568,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,72,Up,0.510587374385582,0.738803324226921
569,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Up,0.511410086964864,0.738803324226921
570,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Up,0.513398179897945,0.739702017765076
571,WP_TCELL_ACTIVATION_SARSCOV2,63,Down,0.514532143542953,0.739702017765076
572,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Up,0.514731817714871,0.739702017765076
573,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Up,0.516879674529442,0.740402891594775
574,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Down,0.517020997293675,0.740402891594775
575,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Down,0.521105773482337,0.74495468835214
576,WP_MESODERMAL_COMMITMENT_PATHWAY,77,Down,0.522335626053489,0.745416466347167
577,WP_AMINO_ACID_METABOLISM,59,Up,0.524434147349592,0.747114157922642
578,WP_13Q1212_COPY_NUMBER_VARIATION,20,Down,0.530655228361222,0.753416354319919
579,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,31,Down,0.531257039487223,0.753416354319919
580,WP_DNA_DAMAGE_RESPONSE,58,Up,0.532194684641523,0.753416354319919
581,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Down,0.532524211508361,0.753416354319919
582,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,48,Down,0.534748386087291,0.754135543816931
583,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,27,Down,0.534867423412739,0.754135543816931
584,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,8,Down,0.537501832746148,0.756552237187216
585,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Down,0.540696330275089,0.758159960894432
586,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Up,0.541961364192496,0.758159960894432
587,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Down,0.542108992286957,0.758159960894432
588,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.542333402683609,0.758159960894432
589,WP_NUCLEAR_RECEPTORS_METAPATHWAY,180,Down,0.544032918420251,0.759244582243543
590,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,9,Up,0.546831732892256,0.759337262841499
591,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,9,Up,0.546831732892256,0.759337262841499
592,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,52,Down,0.546870632119425,0.759337262841499
593,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,62,Down,0.550642504791181,0.761680974964214
594,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Down,0.550947689779331,0.761680974964214
595,WP_ECTODERM_DIFFERENTIATION,78,Down,0.551338418617649,0.761680974964214
596,WP_ALZHEIMERS_DISEASE,185,Down,0.553572070580048,0.762204760497152
597,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,185,Down,0.553572070580048,0.762204760497152
598,WP_ZINC_HOMEOSTASIS,22,Up,0.555342942335954,0.76237973213512
599,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Up,0.555554087042502,0.76237973213512
600,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,4,Up,0.558152564383056,0.764669013204787
601,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Down,0.56331160597446,0.769314629797133
602,WP_15Q11Q13_COPY_NUMBER_VARIATION,36,Up,0.563415337150699,0.769314629797133
603,WP_HEDGEHOG_SIGNALING_WP47,6,Up,0.564810861593331,0.769402643415557
604,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Down,0.566044587095357,0.769402643415557
605,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.566311187403465,0.769402643415557
606,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,59,Up,0.567223846605629,0.769402643415557
607,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Up,0.574037738126216,0.776083915690377
608,WP_HEME_BIOSYNTHESIS,8,Up,0.574037738126216,0.776083915690377
609,WP_CORI_CYCLE,12,Down,0.578322245032067,0.78035780689096
610,WP_SMALL_LIGAND_GPCRS,7,Down,0.579097642583316,0.78035780689096
611,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,36,Down,0.582641700300836,0.783848572254152
612,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,48,Down,0.583765313598612,0.784076940813821
613,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Down,0.587043220669357,0.787193356264619
614,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.590662076020992,0.78869075996107
615,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Up,0.591086980265609,0.78869075996107
616,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Up,0.591086980265609,0.78869075996107
617,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Down,0.591997808875889,0.78869075996107
618,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Up,0.594831241236613,0.78903453404176
619,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Down,0.595656130214968,0.78903453404176
620,WP_CALORIC_RESTRICTION_AND_AGING,7,Up,0.597174587533749,0.78903453404176
621,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Up,0.597229076657549,0.78903453404176
622,WP_MIRNA_BIOGENESIS,6,Up,0.598095872884296,0.78903453404176
623,WP_GASTRIC_CANCER_NETWORK_1,18,Up,0.599027329264702,0.78903453404176
624,WP_AEROBIC_GLYCOLYSIS,10,Up,0.599331226449136,0.78903453404176
625,WP_ACUTE_VIRAL_MYOCARDITIS,65,Down,0.599935016759246,0.78903453404176
626,WP_HEDGEHOG_SIGNALING_WP4249,25,Down,0.601169381528552,0.789394938684457
627,WP_METHYLATION_PATHWAYS,5,Up,0.604031340666831,0.791887977716324
628,WP_KLEEFSTRA_SYNDROME,25,Down,0.606853317912788,0.792971919493339
629,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Up,0.607855044429714,0.792971919493339
630,WP_EPO_RECEPTOR_SIGNALING,23,Up,0.608732152538466,0.792971919493339
631,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Down,0.609148026293133,0.792971919493339
632,WP_GPR40_PATHWAY,10,Down,0.609681573138431,0.792971919493339
633,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Down,0.610981212924141,0.793406883133719
634,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Down,0.611985766274883,0.793457886242829
635,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Down,0.614814308830254,0.795869861194439
636,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,4,Down,0.619169225492591,0.800247017853631
637,WP_KALLMANN_SYNDROME,11,Down,0.625548263320262,0.80690678228798
638,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Up,0.626285312773396,0.80690678228798
639,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Up,0.629669827252338,0.808709941196814
640,WP_SERINE_METABOLISM,7,Up,0.629828777420811,0.808709941196814
641,WP_15Q25_COPY_NUMBER_VARIATION,28,Up,0.630636341006275,0.808709941196814
642,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,47,Down,0.634853991509531,0.812433125411299
643,WP_FATTY_ACID_OMEGAOXIDATION,2,Up,0.635798864771228,0.812433125411299
644,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,3,Down,0.637389491471921,0.812433125411299
645,WP_PPARALPHA_PATHWAY,15,Up,0.637493145851932,0.812433125411299
646,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,3,Up,0.641764465031626,0.816610511232192
647,WP_MATRIX_METALLOPROTEINASES,8,Down,0.643169510080537,0.817133442482537
648,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Up,0.648040147310784,0.821947635124722
649,WP_CELLULAR_PROTEOSTASIS,6,Up,0.648958655956137,0.821947635124722
650,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,12,Up,0.653331032093887,0.826212474432577
651,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Down,0.655405740979423,0.826622791026387
652,WP_GDNFRET_SIGNALING_AXIS,4,Up,0.655666739354263,0.826622791026387
653,WP_GALANIN_RECEPTOR_PATHWAY,10,Down,0.659024526767988,0.82958370750886
654,WP_GLIAL_CELL_DIFFERENTIATION,4,Down,0.660747803033858,0.830481183629712
655,WP_4P163_COPY_NUMBER_VARIATION,22,Up,0.662411653167969,0.831301341838275
656,WP_PRIMARY_OVARIAN_INSUFFICIENCY,90,Up,0.663862300740856,0.831629176590018
657,WP_VITAMIN_B12_METABOLISM,25,Down,0.664696312675964,0.831629176590018
658,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Down,0.668569441268662,0.835203770095502
659,WP_CIRCADIAN_RHYTHM_GENES,122,Down,0.671047624370297,0.835580566930413
660,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,17,Down,0.672320166090468,0.835580566930413
661,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,17,Up,0.673754315635079,0.835580566930413
662,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,56,Down,0.673757807374461,0.835580566930413
663,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Up,0.67529488056892,0.835580566930413
664,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Up,0.675419282379594,0.835580566930413
665,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.676033527820866,0.835580566930413
666,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,11,Down,0.677324662961612,0.835580566930413
667,WP_UREA_CYCLE_AND_RELATED_DISEASES,4,Down,0.678334214822505,0.835580566930413
668,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Down,0.679036275802331,0.835580566930413
669,WP_CELL_CYCLE,96,Up,0.681759823108931,0.83767798893205
670,WP_ALPHA_6_BETA_4_SIGNALING,26,Down,0.685258946224665,0.840720677308469
671,WP_NEPHROGENESIS,4,Up,0.686680095480017,0.84120870116926
672,WP_NRF2ARE_REGULATION,20,Up,0.688499673614075,0.84218263647436
673,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Down,0.690532805334125,0.843414511121324
674,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,22,Up,0.693696521190507,0.8438204379152
675,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,126,Down,0.693842159983206,0.8438204379152
676,WP_APOPTOSIS_MODULATION_AND_SIGNALING,79,Down,0.693944788358486,0.8438204379152
677,WP_IL6_SIGNALING,38,Down,0.695336781478177,0.844264157127122
678,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Up,0.696997809284709,0.845032742230134
679,WP_BIOGENIC_AMINE_SYNTHESIS,1,Down,0.70002399470363,0.846205475950565
680,WP_NEUROTRANSMITTER_DISORDERS,1,Down,0.70002399470363,0.846205475950565
681,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Down,0.705293590882417,0.851323541417543
682,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Up,0.707858766754558,0.853072812947098
683,WP_OXIDATIVE_DAMAGE_RESPONSE,32,Down,0.708818407838039,0.853072812947098
684,WP_MALE_INFERTILITY,71,Up,0.713191472433838,0.854438554645351
685,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Down,0.714733962999116,0.854438554645351
686,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.714938628440277,0.854438554645351
687,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,3,Up,0.715046251930076,0.854438554645351
688,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Down,0.715695780590157,0.854438554645351
689,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,33,Down,0.716189980718548,0.854438554645351
690,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,13,Down,0.720426707863565,0.858247469367899
691,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Up,0.728045900513599,0.86606907412761
692,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,38,Up,0.729770796845284,0.866866466772866
693,WP_NRF2_PATHWAY,74,Up,0.733394502339488,0.868028053923865
694,WP_PANCREATIC_CANCER_SUBTYPES,5,Down,0.733496706179479,0.868028053923865
695,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Up,0.734209089846868,0.868028053923865
696,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,19,Down,0.734972658796849,0.868028053923865
697,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,16,Down,0.743462764218248,0.872165250436685
698,WP_ID_SIGNALING,12,Down,0.745793611814711,0.872165250436685
699,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Down,0.746432872476949,0.872165250436685
700,WP_NAD_BIOSYNTHETIC_PATHWAYS,19,Down,0.74703790932675,0.872165250436685
701,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,43,Down,0.747316635374283,0.872165250436685
702,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,30,Down,0.747435187061263,0.872165250436685
703,WP_FATTY_ACID_BETAOXIDATION,29,Up,0.748477960037707,0.872165250436685
704,WP_TRANSLATION_FACTORS,49,Down,0.748489013760798,0.872165250436685
705,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Down,0.749075042604063,0.872165250436685
706,WP_ALLOGRAFT_REJECTION,51,Down,0.749085969353162,0.872165250436685
707,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,11,Up,0.753082398828313,0.875578121410005
708,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,2,Up,0.759221394593747,0.880552749095035
709,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Down,0.759503526895839,0.880552749095035
710,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,13,Down,0.76799107289534,0.883388716555587
711,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Up,0.768705069779149,0.883388716555587
712,WP_MEASLES_VIRUS_INFECTION,101,Down,0.769047949632926,0.883388716555587
713,WP_TYPE_II_INTERFERON_SIGNALING,30,Down,0.769603037975618,0.883388716555587
714,WP_KININKALLIKREIN_PATHWAY,2,Down,0.770714633104344,0.883388716555587
715,WP_CYTOSOLIC_DNASENSING_PATHWAY,54,Up,0.770898644595613,0.883388716555587
716,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Up,0.772517766382997,0.883388716555587
717,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Down,0.772994967541092,0.883388716555587
718,WP_FLUOROPYRIMIDINE_ACTIVITY,26,Down,0.773097553260268,0.883388716555587
719,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,20,Down,0.773446337173457,0.883388716555587
720,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,18,Up,0.773771138588835,0.883388716555587
721,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,35,Down,0.780972690538022,0.8903738580059
722,WP_VALPROIC_ACID_PATHWAY,9,Down,0.782797338170105,0.890520126002283
723,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Up,0.783267702067702,0.890520126002283
724,WP_IRON_METABOLISM_IN_PLACENTA,8,Up,0.787282591368665,0.893848466995915
725,WP_NRXN1_DELETION_SYNDROME,2,Up,0.798160042273099,0.904948351377224
726,WP_FATTY_ACID_BIOSYNTHESIS,21,Up,0.800273208257445,0.905546743125191
727,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.800891097630188,0.905546743125191
728,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,20,Up,0.804209420265013,0.907771912962029
729,WP_OXIDATIVE_STRESS_RESPONSE,21,Down,0.805067791422529,0.907771912962029
730,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Down,0.815151518443151,0.915851921291796
731,WP_TRYPTOPHAN_METABOLISM,18,Up,0.816261481455534,0.915851921291796
732,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,9,Up,0.816432913535758,0.915851921291796
733,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,37,Down,0.817663329103773,0.915851921291796
734,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,15,Down,0.819384880034236,0.915851921291796
735,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,4,Up,0.819891678936426,0.915851921291796
736,WP_ATM_SIGNALING,34,Up,0.820032863833043,0.915851921291796
737,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,26,Down,0.823020585794489,0.917941548877978
738,WP_COPPER_HOMEOSTASIS,40,Down,0.82639131895313,0.919302894516889
739,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Down,0.826477906384405,0.919302894516889
740,WP_ALSTROM_SYNDROME,27,Up,0.827667885929381,0.919382435451285
741,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Down,0.829499981629757,0.919929229405401
742,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Up,0.830398404159133,0.919929229405401
743,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,40,Down,0.833583556689451,0.922063046616276
744,WP_EICOSANOID_SYNTHESIS,14,Down,0.834568012995753,0.922063046616276
745,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.836350333738074,0.922791911855968
746,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,15,Up,0.840663694385929,0.926307716870287
747,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Up,0.841810726134097,0.926329875344348
748,WP_MRNA_PROCESSING,124,Down,0.84396322274518,0.926507898938424
749,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Up,0.844226783825887,0.926507898938424
750,WP_TP53_NETWORK,16,Down,0.84602454501351,0.927242901334807
751,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,18,Down,0.850856738398975,0.931297255611129
752,WP_ULCERATIVE_COLITIS_SIGNALING,12,Down,0.856666193790687,0.935275268105656
753,WP_LEUKOTRIENE_METABOLIC_PATHWAY,9,Down,0.858412104012938,0.935275268105656
754,WP_LIPID_METABOLISM_PATHWAY,23,Up,0.859232982350157,0.935275268105656
755,WP_PEPTIDE_GPCRS,14,Down,0.859469859617172,0.935275268105656
756,WP_GABA_METABOLISM_AKA_GHB,4,Down,0.860279946925796,0.935275268105656
757,WP_STEROID_BIOSYNTHESIS,3,Up,0.864581429779627,0.935275268105656
758,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Down,0.865012835456777,0.935275268105656
759,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,18,Down,0.865378237727623,0.935275268105656
760,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Up,0.865828779976308,0.935275268105656
761,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,42,Up,0.865869195898302,0.935275268105656
762,WP_FOXA2_PATHWAY,10,Up,0.868809391013556,0.93685683911447
763,WP_PPAR_SIGNALING,39,Up,0.86961285674494,0.93685683911447
764,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Down,0.873166108381664,0.938463831598465
765,WP_ACUTE_MYELOID_LEUKEMIA,56,Down,0.873744309595725,0.938463831598465
766,WP_MTHFR_DEFICIENCY,18,Down,0.874529555966453,0.938463831598465
767,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Down,0.882255632629017,0.945520378123927
768,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Down,0.885313681136608,0.945669746981561
769,WP_IL9_SIGNALING,15,Up,0.88669995691469,0.945669746981561
770,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,21,Down,0.887202526166641,0.945669746981561
771,WP_IL17_SIGNALING,25,Up,0.887250092882406,0.945669746981561
772,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Up,0.88881454006824,0.945669746981561
773,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.889305222389881,0.945669746981561
774,WP_5Q35_COPY_NUMBER_VARIATION,78,Down,0.891082349184813,0.945669746981561
775,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Down,0.891598605730791,0.945669746981561
776,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,12,Up,0.894431760514653,0.947452199926604
777,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Down,0.89677717576228,0.948714077833455
778,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,41,Up,0.901202199944263,0.952169933617203
779,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Up,0.904702713791862,0.954641374501811
780,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,38,Down,0.909746014898212,0.958732338777347
781,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,11,Up,0.912016796797292,0.959894759241196
782,WP_16P112_PROXIMAL_DELETION_SYNDROME,62,Up,0.91322495111359,0.959937224827841
783,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Up,0.915021289061368,0.960391952554122
784,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.915994271049187,0.960391952554122
785,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Down,0.917432715049295,0.960674766586651
786,WP_BARDETBIEDL_SYNDROME,65,Up,0.92227638809678,0.964518054727167
787,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Up,0.929305325080639,0.968894317215213
788,WP_UNFOLDED_PROTEIN_RESPONSE,24,Down,0.92964251901843,0.968894317215213
789,WP_CILIARY_LANDSCAPE,186,Down,0.929997100100734,0.968894317215213
790,WP_SILDENAFIL_TREATMENT,11,Up,0.931402636885234,0.969130338632484
791,WP_APOPTOSIS,73,Up,0.934452989759726,0.969830685903928
792,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,15,Up,0.935099025557817,0.969830685903928
793,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Up,0.935860333893267,0.969830685903928
794,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Down,0.936795090763648,0.969830685903928
795,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Down,0.939341852767631,0.971244028899362
796,WP_METABOLIC_EPILEPTIC_DISORDERS,61,Down,0.947041004738065,0.977974504892826
797,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Up,0.950093160605613,0.97945083035947
798,WP_ENDOTHELIN_PATHWAYS,12,Down,0.950853725823427,0.97945083035947
799,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.952366159742664,0.97978095532975
800,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,26,Up,0.954148590602171,0.980387676843731
801,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,41,Down,0.95663314362593,0.98135787255335
802,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,16,Up,0.958347249641386,0.98135787255335
803,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Down,0.958674418078272,0.98135787255335
804,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Down,0.961658409140036,0.982186081899517
805,WP_ESTROGEN_SIGNALING,21,Up,0.962175418439524,0.982186081899517
806,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Up,0.963068104636266,0.982186081899517
807,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Down,0.965325937929891,0.983268799229703
808,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Up,0.967676703011659,0.984087133981375
809,WP_FOLATE_METABOLISM,38,Down,0.968678391204552,0.984087133981375
810,WP_MACROPHAGE_MARKERS,8,Down,0.970597765294521,0.984087133981375
811,WP_PYRIMIDINE_METABOLISM,73,Up,0.970918084743182,0.984087133981375
812,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Down,0.973361026762126,0.984746605255623
813,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,12,Up,0.974016619085862,0.984746605255623
814,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,11,Up,0.975711818077665,0.984746605255623
815,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Down,0.977284285826851,0.984746605255623
816,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Down,0.9775586738304,0.984746605255623
817,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Down,0.980624229207811,0.986625601479584
818,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Up,0.983778175872586,0.988588827099347
819,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Up,0.989224384331538,0.992847916874877
820,WP_PROTEASOME_DEGRADATION,57,Up,0.99106867668175,0.993485917356583
821,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Down,0.993425494425079,0.994635513297704
822,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Down,0.997805298579785,0.997805298579785
